Thank you to Dr Sundar Jagannath, MD @TischCancer & @AACR #AACR24 for sitting down with us to discuss his research on #linvoseltamab for #RRMM Video will be released tomorrow after the presentation https://www.abstractsonline.com/pp8 @Regeneron
2Oncology Conference Videos
Oncology News
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…
Allen Wilbanks stood alongside Alina Hamilton, PhD, at the SABCS 2023 event, where they delved…
Amidst the atmosphere of SABCS 2023, and at the center was Yara Abdou, MD, a…
At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…
At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…
In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…
By. Ash Alizadeh, MD Date: 12/13/2023 At ASH 2023, Dr. Ash Alizadeh, a distinguished medical…
Hamish Scott, MD, serves as the Head of the Department of Genetics and Molecular Pathology…
By: Joyti Bajpai, MD Date: 12/07/2023 In a forthcoming interview, Jyoti Bajpai, MD, a renowned…
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…